If your organisation wants to reduce stigma but isn't sure where to start, this paper offers one of the clearest roadmaps available. Drawing on 42 stigma reduction interventions from around the world, the authors identified six common approaches used to tackle stigma in healthcare settings:

This free, online CPD-accredited module from Hep C U Later focuses specifically on hepatitis C–related stigma and its impact on care, engagement, and outcomes.

In this short film, the International Network on Health and Hepatitis in Substance Users (INHSU) explores how language can reduce stigma and discrimination against people who use drugs.

Published in Hepatology, this global consensus statement brought together 236 experts and patient advocates from 56 countries to review the terminology used for fatty liver disease. The aim was to reduce stigma and improve clarity in diagnosis.

This commentary, published in Nature Medicine on June 5, 2025, calls for a shift in how liver diseases are talked about to reduce stigma and discrimination.

This pilot study, led by the European Centre for Disease Prevention and Control and the World Hepatitis Alliance, tested a new survey tool in nine European countries to explore stigma and discrimination faced by people living with hepatitis B and C.

Hosted by the Hepatitis C Mentor and Support Group, this recorded webinar explores the real-world impact of hepatitis C stigma—from healthcare settings to daily life.

This DocuStory film captures powerful conversations on wellness, sharing personal and professional stories from across different walks of life. Through these voices, the film highlights the vital role the Indigenous community plays in raising awareness about liver health.

A new survey by the World Hepatitis Alliance and European Centre for Disease Prevention and Control (ECDC), highlights the impact of stigma on people living with hepatitis b and C.